Recap: Harmony Biosciences Q3 Earnings

Harmony Biosciences HRMY reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Harmony Biosciences posted an EPS of $0.95.

Revenue was up $36.47 million from the same period last year.

Last quarter the company beat on EPS by $0.13 which was followed by a 5.59% drop in the share price the next day.

Here's a look at Harmony Biosciences's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	0.44	0.29	0.37	0.28
EPS Actual	0.57	0.51	0.63	0.51
Revenue Estimate	100.75M	88.55M	90.01M	79.85M
Revenue Actual	107.03M	85.31M	91.21M	80.73M

To track all earnings releases for Harmony Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar